TOCILIZUMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10068XMP | TOCILIZUMAB tocilizumab 80 mg/4 mL injection, 4 mL vial (PI, CMI) |
1 | 1 | 0 | $93.85 | $31.60 | $31.60 |
| Available brands | |||||||
| Actemra |
TOCILIZUMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10073EMP | TOCILIZUMAB tocilizumab 80 mg/4 mL injection, 4 mL vial (PI, CMI) |
1 | 1 | 0 | $93.85 | $31.60 | $31.60 |
| Available brands | |||||||
| Actemra |
TOCILIZUMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10077JMP | TOCILIZUMAB tocilizumab 80 mg/4 mL injection, 4 mL vial (PI, CMI) |
1 | 1 | 0 | $80.97 | $31.60 | $31.60 |
| Available brands | |||||||
| Actemra |
TOCILIZUMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10081NMP | TOCILIZUMAB tocilizumab 80 mg/4 mL injection, 4 mL vial (PI, CMI) |
1 | 1 | 0 | $80.97 | $31.60 | $31.60 |
| Available brands | |||||||
| Actemra |
TOCILIZUMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12775JMP | TOCILIZUMAB tocilizumab 80 mg/4 mL injection, 4 mL vial (PI, CMI) |
1 | 1 | 0 | $80.97 | $31.60 | $31.60 |
| Available brands | |||||||
| Actemra |
TOCILIZUMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12787BMP | TOCILIZUMAB tocilizumab 80 mg/4 mL injection, 4 mL vial (PI, CMI) |
1 | 1 | 0 | $93.85 | $31.60 | $31.60 |
| Available brands | |||||||
| Actemra |
TOCILIZUMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12794JMP | TOCILIZUMAB tocilizumab 80 mg/4 mL injection, 4 mL vial (PI, CMI) |
1 | 1 | 0 | $80.97 | $31.60 | $31.60 |
| Available brands | |||||||
| Actemra |
TOCILIZUMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12811GMP | TOCILIZUMAB tocilizumab 80 mg/4 mL injection, 4 mL vial (PI, CMI) |
1 | 1 | 0 | $93.85 | $31.60 | $31.60 |
| Available brands | |||||||
| Actemra |
TOCILIZUMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13304FMP | TOCILIZUMAB tocilizumab 80 mg/4 mL injection, 4 mL vial (PI, CMI) |
4 | 4 | 5 | $323.88 | $31.60 | $31.60 |
| Available brands | |||||||
| Actemra |
TOCILIZUMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13311NMP | TOCILIZUMAB tocilizumab 80 mg/4 mL injection, 4 mL vial (PI, CMI) |
2 | 2 | 5 | $177.30 | $31.60 | $31.60 |
| Available brands | |||||||
| Actemra |
TOCILIZUMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13315TMP | TOCILIZUMAB tocilizumab 80 mg/4 mL injection, 4 mL vial (PI, CMI) |
4 | 4 | 5 | $345.72 | $31.60 | $31.60 |
| Available brands | |||||||
| Actemra |
TOCILIZUMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13324GMP | TOCILIZUMAB tocilizumab 80 mg/4 mL injection, 4 mL vial (PI, CMI) |
2 | 2 | 5 | $161.94 | $31.60 | $31.60 |
| Available brands | |||||||
| Actemra |
TOCILIZUMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13690MMP | TOCILIZUMAB tocilizumab 80 mg/4 mL injection, 4 mL vial (PI, CMI) |
2 | 2 | 5 | $161.94 | $31.60 | $31.60 |
| Available brands | |||||||
| Actemra |
TOCILIZUMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13696WMP | TOCILIZUMAB tocilizumab 80 mg/4 mL injection, 4 mL vial (PI, CMI) |
2 | 2 | 5 | $177.30 | $31.60 | $31.60 |
| Available brands | |||||||
| Actemra |
TOCILIZUMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 1419QMP | TOCILIZUMAB tocilizumab 80 mg/4 mL injection, 4 mL vial (PI, CMI) |
1 | 1 | 0 | $93.85 | $31.60 | $31.60 |
| Available brands | |||||||
| Actemra |
TOCILIZUMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 1476QMP | TOCILIZUMAB tocilizumab 80 mg/4 mL injection, 4 mL vial (PI, CMI) |
1 | 1 | 0 | $80.97 | $31.60 | $31.60 |
| Available brands | |||||||
| Actemra |
TOCILIZUMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9657GMP | TOCILIZUMAB tocilizumab 80 mg/4 mL injection, 4 mL vial (PI, CMI) |
1 | 1 | 0 | $80.97 | $31.60 | $31.60 |
| Available brands | |||||||
| Actemra |
TOCILIZUMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9671BMP | TOCILIZUMAB tocilizumab 80 mg/4 mL injection, 4 mL vial (PI, CMI) |
1 | 1 | 0 | $93.85 | $31.60 | $31.60 |
| Available brands | |||||||
| Actemra |
- Legend
- MPMedical Practitioner




